AR021502A1 - USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES - Google Patents
USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASESInfo
- Publication number
- AR021502A1 AR021502A1 ARP990105979A ARP990105979A AR021502A1 AR 021502 A1 AR021502 A1 AR 021502A1 AR P990105979 A ARP990105979 A AR P990105979A AR P990105979 A ARP990105979 A AR P990105979A AR 021502 A1 AR021502 A1 AR 021502A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- substituted
- derivatives
- azabicicloalcan
- central system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se describe el uso de derivados de azabicicloalcanos N-sustituidos de la formula (1) donde: B, R1, R2 y n tienen los significados indicados en ladescripcion, para el tratamiento de enfermedades de adiccion y otras enfermedades del sistema central nervioso.The use of N-substituted azabicycloalkane derivatives of the formula (1) is described where: B, R1, R2 and n have the meanings indicated in the description, for the treatment of addiction diseases and other diseases of the central nervous system.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19854147A DE19854147A1 (en) | 1998-11-24 | 1998-11-24 | Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR021502A1 true AR021502A1 (en) | 2002-07-24 |
Family
ID=7888824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990105979A AR021502A1 (en) | 1998-11-24 | 1999-11-24 | USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1133293A1 (en) |
| JP (1) | JP2002530333A (en) |
| KR (1) | KR20010080535A (en) |
| CN (1) | CN1328455A (en) |
| AR (1) | AR021502A1 (en) |
| AU (1) | AU1775300A (en) |
| BG (1) | BG105549A (en) |
| BR (1) | BR9915589A (en) |
| CA (1) | CA2352526A1 (en) |
| CZ (1) | CZ20011796A3 (en) |
| DE (1) | DE19854147A1 (en) |
| HK (1) | HK1040933A1 (en) |
| HR (1) | HRP20010472A2 (en) |
| HU (1) | HUP0104416A3 (en) |
| IL (1) | IL143181A0 (en) |
| NO (1) | NO20012538L (en) |
| PL (1) | PL348758A1 (en) |
| SK (1) | SK7112001A3 (en) |
| TR (1) | TR200101476T2 (en) |
| WO (1) | WO2000030639A1 (en) |
| ZA (1) | ZA200103976B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0519013A2 (en) | 2004-12-13 | 2009-11-03 | Lilly Co Eli | single compound or stereoisomers, mixtures of pharmaceutically acceptable stereoisomers, salts, tautomers or prodrugs thereof, pharmaceutical composition, and use of a compound |
| GB0812310D0 (en) | 2008-07-03 | 2008-08-13 | Syngenta Ltd | Novel herbicides |
| WO2014111837A1 (en) * | 2013-01-15 | 2014-07-24 | Novartis Ag | Use of alpha 7 nicotinic acetylcholine receptor agonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0348460A4 (en) * | 1987-11-12 | 1991-11-27 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
| DE4427648A1 (en) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use |
| DE4341403A1 (en) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituted 3-azabicycloalkane derivatives, their preparation and use |
| DE4427647A1 (en) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-substituted azabicycloheptane derivatives, their preparation and use |
-
1998
- 1998-11-24 DE DE19854147A patent/DE19854147A1/en not_active Withdrawn
-
1999
- 1999-11-12 AU AU17753/00A patent/AU1775300A/en not_active Abandoned
- 1999-11-12 KR KR1020017006445A patent/KR20010080535A/en not_active Application Discontinuation
- 1999-11-12 PL PL99348758A patent/PL348758A1/en not_active Application Discontinuation
- 1999-11-12 SK SK711-2001A patent/SK7112001A3/en unknown
- 1999-11-12 JP JP2000583522A patent/JP2002530333A/en active Pending
- 1999-11-12 IL IL14318199A patent/IL143181A0/en unknown
- 1999-11-12 TR TR2001/01476T patent/TR200101476T2/en unknown
- 1999-11-12 HU HU0104416A patent/HUP0104416A3/en unknown
- 1999-11-12 CZ CZ20011796A patent/CZ20011796A3/en unknown
- 1999-11-12 CN CN99813559A patent/CN1328455A/en active Pending
- 1999-11-12 WO PCT/EP1999/008734 patent/WO2000030639A1/en not_active Application Discontinuation
- 1999-11-12 CA CA002352526A patent/CA2352526A1/en not_active Abandoned
- 1999-11-12 EP EP99960974A patent/EP1133293A1/en not_active Withdrawn
- 1999-11-12 BR BR9915589-3A patent/BR9915589A/en not_active IP Right Cessation
- 1999-11-24 AR ARP990105979A patent/AR021502A1/en unknown
-
2001
- 2001-05-16 ZA ZA200103976A patent/ZA200103976B/en unknown
- 2001-05-23 NO NO20012538A patent/NO20012538L/en not_active Application Discontinuation
- 2001-05-30 BG BG105549A patent/BG105549A/en unknown
- 2001-06-21 HR HR20010472A patent/HRP20010472A2/en not_active Application Discontinuation
-
2002
- 2002-04-12 HK HK02102768.4A patent/HK1040933A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20011796A3 (en) | 2002-05-15 |
| KR20010080535A (en) | 2001-08-22 |
| WO2000030639A1 (en) | 2000-06-02 |
| BR9915589A (en) | 2001-08-07 |
| NO20012538L (en) | 2001-07-04 |
| HK1040933A1 (en) | 2002-06-28 |
| CA2352526A1 (en) | 2000-06-02 |
| PL348758A1 (en) | 2002-06-03 |
| HUP0104416A2 (en) | 2002-04-29 |
| NO20012538D0 (en) | 2001-05-23 |
| IL143181A0 (en) | 2002-04-21 |
| JP2002530333A (en) | 2002-09-17 |
| SK7112001A3 (en) | 2001-12-03 |
| AU1775300A (en) | 2000-06-13 |
| EP1133293A1 (en) | 2001-09-19 |
| HRP20010472A2 (en) | 2003-04-30 |
| CN1328455A (en) | 2001-12-26 |
| BG105549A (en) | 2001-12-29 |
| DE19854147A1 (en) | 2000-05-25 |
| ZA200103976B (en) | 2002-05-16 |
| TR200101476T2 (en) | 2001-10-22 |
| HUP0104416A3 (en) | 2002-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0585328T3 (en) | Substituted 3-aminoquinuclidines | |
| NO931635D0 (en) | PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES | |
| EA200200208A1 (en) | SYNERGY COMPOSITION | |
| ES2191192T3 (en) | TIENOPIRIMIDINAS. | |
| ATE172971T1 (en) | HETEROCYCLIC NEUROKININ ANTAGONISTS | |
| CY1108339T1 (en) | SPIRO DERIVATIVES (2H-1-BENZOPYRAN-2,4IP-PIPERIDINE) AS GLYCINE TRANSPORT INHIBITORS | |
| BR0316296A (en) | Lapacone compounds and their methods of use | |
| AR028705A1 (en) | BIS-ARILSULPHONES | |
| BR0015416A (en) | Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders | |
| HN1999000146A (en) | PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS. | |
| EA200200742A1 (en) | 1,2-DIARYLBENZYMIDAZOLEY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLY | |
| ES2101858T3 (en) | GENESERINE DERIVATIVES AS CHOLINESTERASE INHIBITORS. | |
| ES2084996T3 (en) | SUBSTITUTED PIPERAZINES USEFUL AS AGENTS FOR THE CENTRAL NERVOUS SYSTEM. | |
| ES2063202T3 (en) | NEW 5,11-DIHIDRO-6H-DIPIRIDO (3,2-B: 2 ', 3'-E) (1,4) DIAZEPIN-6-ONAS Y -TIONAS AND ITS USE IN THE PREVENTION OR TREATMENT OF AIDS. | |
| DE60115466D1 (en) | ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES | |
| TR200101149T2 (en) | Treatment of external retinal disorders. | |
| ATE369348T1 (en) | CYCLIZED BENZAMIDE NEUROKININ ANTAGONISTS FOR USE IN THERAPY | |
| AR020563A1 (en) | TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE | |
| TR200001102T2 (en) | Substituted tetrahydropyrimidinene derivatives, their production and uses. | |
| ATE236134T1 (en) | ISOQUINOLINAMINE AND PHTALAZINAMINE DERIVATIVES THAT REACT WITH CRF RECEPTORS | |
| ES2196069T3 (en) | MORFINOID DERIVATIVES CONDENSED WITH HETEROCICLES. | |
| MX9700813A (en) | New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments. | |
| PT916670E (en) | PYRROLE- (3,2-B) PYRIDINES AND THEIR USE AS 5-HT1F AGONISTS | |
| ATE330958T1 (en) | PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES | |
| AR021502A1 (en) | USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES |